| Name | Title | Contact Details |
|---|
Altheus Therapeutics is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Presbyterian Homes & Services (PHS), based in St. Paul, Minnesota, is a non-profit, faith-based organization providing a broad array of high quality housing choices, and care and service options for older adults. Over 7,100 employees serve more than 26,000 older adults through 59 PHS-affiliated senior living communities in Minnesota, Iowa and Wisconsin, and through Optage® home and community services. PHS is also co-owner of Genevive, the largest geriatric primary care practice in Minnesota, providing comprehensive care for over 15,000 older adults. Established in 1955, PHS has earned the reputation as an innovative leader dedicated to promoting independence, purposeful living, and overall well-being for those they serve. Today, PHS is one of the largest nonprofit providers of senior housing and services in the nation. The mission of Presbyterian Homes & Services is to honor God by enriching the lives and touching the hearts of older adults. By living our values in our daily work, we create smiles in the eyes of the people we serve. These value statements form the word “CROSS” and are central to how we do what we do: Christian Ministry - Reflect the love of God Ready and Engaged People - Create ownership and utilize strengths Operational Integrity - Do what we said we would do Service Excellence - Create an exceptional customer experience Stewardship - Optimize resources and expand ministry
GGB Industries Inc is a Naples, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
HMI Corporation is a Brentwood, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cleveland BioLabs, Inc. (NASDAQ: CBLI) is an innovative bio pharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. Our proprietary platform of toll-like immune receptor activators has applications in radiation mitigation, oncology immunotherapy, and vaccines. We combine our proven scientific expertise and our depth of knowledge about our products’ mechanisms of action into a passion for developing drugs to save lives. Our proprietary drug candidates act via unique mechanisms that are designed to kill cancer and protect healthy cells. Our most advanced product candidate is entolimod, which we are developing as a radiation countermeasure and an immunotherapy for oncology and other indications. We have additional pipeline product candidates in various stages of development.